Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Manvitha Pharmaceuticals Private Limited, was an unlisted private company incorporated on 24 April, 2017. It is classified as a private limited company and is located in , Delhi. It's authorized share capital was INR 10.00 lac and the total paid-up capital was INR 5.00 lac.
The current status of Manvitha Pharmaceuticals Private Limited is - Strike Off.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Girish Ramdular Verma | 05267094 | 8 years |
Director | Hari Shanker Pandey | 08227435 | 7 years |
Director | Sonu Pandey | 08638131 | 8 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
GAR INFRA REALITY PRIVATE LIMITED |
Strike Off
|
5.0 L | 2 | Delhi |
COTERIE MARKETING PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
GAR PRODUCTION HOUSE PRIVATE LIMITED |
Strike Off
|
3.0 L | 2 | Uttar Pradesh |
GAR ECOMMERCE PRIVATE LIMITED |
Active
|
4.7 L | 1 | Uttar Pradesh |
EMERALD NETWORKS PRIVATE LIMITED |
Under Process of Striking Off
|
1.0 L | 2 | Delhi |
GAR HEIGHTS PRIVATE LIMITED |
Active
|
5.0 L | 2 | Uttar Pradesh |
TANAY INFRA PROJECT PRIVATE LIMITED |
Active
|
2.0 L | 2 | Uttar Pradesh |
NEXTRACK INFOSOFT PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Uttar Pradesh |
RIHAMAYA MULTI SERVICES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Uttar Pradesh |
VISHWANATH AAROGYAM PRIVATE LIMITED |
Active
|
1.0 L | 1 | Gujarat |
CELLTO CELL PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
TRIPOREY PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
Read more
The incorporation date of MANVITHA PHARMACEUTICALS PRIVATE LIMITED is 24 April, 2017
The authorized share capital of MANVITHA PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 10.0 L.
The paid-up capital of MANVITHA PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 5.0 L.
The registered address of MANVITHA PHARMACEUTICALS PRIVATE LIMITED is 411, BHAWALPUR APARTMENT DWARKA, SECTOR-4 NEW DELHI South West Delhi Delhi - 110075
The CIN number of MANVITHA PHARMACEUTICALS PRIVATE LIMITED is U51909DL2017PTC316595.